AstraZeneca settles antitrust action; Lundbeck opens plant in China; Takeda expands in vaccines

@FiercePharma: Novartis flu vaccines cleared in Italy: Gov't lifts suspension on Agrippal and Fluad. Release | Follow @FiercePharma

> AstraZeneca ($AZN) will pay as much as $11 million to settle antitrust litigation that alleged the company kept copycats of the heart drug Toprol XL from reaching the market. Story

> Novartis ($NVS) reports that its plant in Colorado has gotten an affirmative review by the FDA perhaps putting its problems there behind it. Story

> Denmark-based Lundbeck is opening a manufacturing plant in Tianjin, China to make drugs for the market there.  Item

> Takeda is expanding its efforts in vaccines to take advantage of that growing market. Story

Medical Device News

 @FierceMedDev: Covidien's Q4 dipped over last year; the company blames currency fluctuations and an extra selling week in 2011. More | Follow @FierceMedDev

 @MarkHFierce: CardiAQ Valve Technologies, based in CA, raised $32.5 million, according to a regulatory filing. More | Follow @MarkHFierce

 @DamianFierce: St. Jude has won a legal injunction in its ongoing spat with supplier AorTech. News | Follow @DamianFierce

> GE grabs U-Systems to boost its breast imaging capabilities. Article

> Baxter recalls infusion sets over deadly embolism risk. News

Biotech News

 @FierceBiotech: More from FierceBiotechResearch.com: Harvard's microchip, lined with living cells, mimics disease in preclinical drug test. More | Follow @FierceBiotech

 @JohnCFierce: CVS blocking drugs on formulary based on price, part of the payer backlash. Also adding a few back in after discounts. News (sub. req.) | Follow @JohnCFierce

 @RyanMFierce: Bristol-Myers struck a discovery deal with Chiromics , focused on small molecules in multiple diseases. Release | Follow @RyanMFierce

> Takeda takes aim at becoming next big vaccine developer. Report

> Cardioxyl Pharma reports $28M equity round with lead drug against heart failure. News

> GSK reports letdown in PhIII malaria vaccine study. Article

> Gates Foundation backs $13M venture add for flu drug developer. News

> FDA advisers endorse Novo Nordisk's key diabetes drug. Story

And Finally... Two people were killed in an explosion in Canada at the Neptune Technologies & Bioressources plant where the company makes products such as Omega-3 derived from krill. Story
 

Suggested Articles

Baxter Biopharma Services will spend $50 million to expand its facility in Bloomington, Indiana, to include fill-finish technology.

The FDA knocked India's Aurolife for chronic water leaks from its ceiling that may have contaminated multiple generic medicines.

The company was simultaneously hoping for an approval of a granules formulation to reach younger patients, but that didn't come as expected.